Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1,081.63% | -90.55% | -39.16% | -35.69% | 8.87% |
| Total Depreciation and Amortization | -21.51% | 559.25% | 1.04% | 5.86% | 1.49% |
| Total Amortization of Deferred Charges | 77.27% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20,485.00% | -81.82% | 110.16% | -241.20% | 123.43% |
| Change in Net Operating Assets | 3,353.23% | -108.77% | 266.84% | 73.00% | -422.78% |
| Cash from Operations | 343.81% | -67.84% | 155.75% | 0.70% | -59.52% |
| Capital Expenditure | 99.99% | -727,354.55% | -83.33% | 95.83% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.99% | -727,354.55% | -83.33% | 95.83% | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 33.96% | -265.52% | -3.57% | 22.22% | -24.14% |
| Issuance of Common Stock | 50.00% | -58.33% | -76.70% | -47.45% | 46.27% |
| Repurchase of Common Stock | -- | -- | 100.00% | 96.55% | -3,764.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.69% | -- | -- | -- | -- |
| Cash from Financing | -100.26% | 790,220.00% | 95.05% | 97.96% | -18,200.00% |
| Foreign Exchange rate Adjustments | -986.54% | 125.24% | -20.47% | -142.01% | 307.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.61% | -740.68% | 178.43% | 195.36% | -139.34% |